Cite
APA Citation
Carrillo Palau, M., Alonso-Abreu, I., Morant, A., Vera, B., Vela, M., Ramos, L., Franco, A., Reygosa, C., Barrios, Y., Medina Chico, J. S., Globio, V., Hernández-Perez, A., Jiménez, A., & Hernández-Guerra, M. (n.d.). p437 Early therapeutic drug monitoring of Adalimumab, but not HLADQ*A1 determination, predicts inflammatory bowel disease outcome. Journal of Crohn's and colitis, 17, i566. http://access.bl.uk/ark:/81055/vdc_100179843904.0x000014